Persisting fatigue in Hodgkin lymphoma survivors: A systematic review

Annals of Hematology

Volumn 92, Issue 8, 2013, Pages 1023-1032

  Daniëls, Laurien A ^a   Oerlemans, Simone ^b,c   Krol, Augustinus D G ^a   Van De Poll Franse, Lonneke V ^b,c   Creutzberg, Carien L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b The Netherlands   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

Author keywords

Fatigue; Health related quality of life; Hodgkin lymphoma; Vitality

Indexed keywords

AGING; CANCER STAGING; CANCER SURVIVOR; COMORBIDITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISTRESS SYNDROME; FATIGUE; HODGKIN DISEASE; HUMAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK FACTOR; SCORING SYSTEM; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; COMORBIDITY; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; SURVIVORS; YOUNG ADULT;

EID: 84880322640     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1793-2     Document Type: Review

References (47)

1. De Bruin ML, Sparidans J, Van't Veer MB et al (2009) Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 27:4239-4246
2. van den Belt-Dusebout AW, Aleman BM, Besseling G et al (2009) Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys 75:1420-1429
3. Aleman BM, van den Belt-Dusebout AW, Klokman WJ et al (2003) Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21:3431-3439
4. van den Belt-Dusebout AW, De WR, Gietema JA et al (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25:4370-4378
5. Fobair P, Hoppe RT, Bloom J et al (1986) Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 4:805-814
6. Flechtner H, Ruffer JU, Henry-Amar M et al (1998) Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group. Ann Oncol 9(Suppl 5):147-154
7. Ganz PA, Moinpour CM, Pauler DK et al (2003) Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group study 9133. J Clin Oncol 21:3512-3519
8. Bloom JR, Fobair P, Gritz E et al (1993) Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 11:979-988
9. Stasi R, Abriani L, Beccaglia P et al (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98:1786-1801
10. Ganz PA, Bower JE (2007) Cancer related fatigue: a focus on breast cancer and Hodgkin's disease survivors. Acta Oncologica 46:474-479
11. Arden-Close E, Pacey A, Eiser C (2010) Health-related quality of life in survivors of lymphoma: a systematic review and methodological critique. Leuk Lymphoma 51:628-640
12. Roper K, McDermott K, Cooley ME et al (2009) Health-related quality of life in adults with Hodgkin's disease: the state of the science. Cancer Nurs 32:E1-E17
13. Henry-Amar M, Joly F (1996) Late complications after Hodgkin's disease. Ann Oncol 7(Suppl 4):115-126
14. Oerlemans S, Mols F, Nijziel MR et al (2011) The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review. Ann Hematol 90:993-1004
15. Den Oudsten BL, Van Heck GL, De VJ (2007) The suitability of patient-based measures in the field of Parkinson's disease: a systematic review. Mov Disord 22:1390-1401
16. Mols F, Vingerhoets AJ, Coebergh JW et al (2005) Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41:2613-2619
17. Cocks K, King MT, Velikova G et al (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 29:89-96
18. Ware JE, Kosinski M, Dewey J (2000) How to score version 2 of the SF-36 health survey. Quality Metric, Lincoln
19. Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582-592
20. Hjermstad MJ, Fossa SD, Oldervoll L et al (2005) Fatigue in long-term Hodgkin's disease survivors: a follow-up study. J Clin Oncol 23:6587-6595
21. Ng AK, Li S, Recklitis C et al (2005) A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 16:1949-1955
22. Ruffer JU, Flechtner H, Tralls P et al (2003) Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39:2179-2186
23. Loge JH, Abrahamsen AF, Ekeberg O et al (1999) Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 17:253-261
24. Loge JH, Abrahamsen AF, Ekeberg O et al (2000) Fatigue and psychiatric morbidity among Hodgkin's disease survivors. J Pain Symptom Manag 19:91-99
25. Knobel H, Loge JH, Lund MB et al (2001) Late medical complications disease and fatigue in Hodgkin's disease survivors. J Clin Oncol 19:3226-3233
26. Khimani N, Chen YH, Mauch PM et al (2013) Influence of new late effects on quality of life over time in Hodgkin lymphoma survivors: a longitudinal survey study. Ann Oncol 24:226-230
27. Hjermstad MJ, Oldervoll L, Fossa SD et al (2006) Quality of life in long-term Hodgkin's disease survivors with chronic fatigue. Eur J Cancer 42:327-333
28. Loge JH, Abrahamsen AF, Ekeberg O et al (1999) Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncol 10:71-77
29. Mols F, Vingerhoets AJJM, Coebergh JW et al (2006) Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study. Eur J Cancer 42:2794-2801
30. Wettergren L, Björkholm M, Axdorph U et al (2004) Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Quality of Life Research. An Int J Qual Life Aspects of Treat Care & Rehabil 13:1369-1379
31. Oldervoll LM, Loge JH, Kaasa S et al (2007) Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study. BMC Cancer 7:210
32. Joly F, HenryAmar M, Arveux P et al (1996) Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study. J Clin Oncol 14:2444-2453
33. Gil-Fernandez JJ, Ramos C, Tamayo AT et al (2003) Quality of life and psychological well-being in Spanish long-term survivors of Hodgkin's disease: results of a controlled pilot study. Ann Hematol 82:14-18
34. van Tulder MW, Aaronson NK, Bruning PF (1994) The quality of life of long-term survivors of Hodgkin's disease. Ann Oncol 5:153-158
35. Brandt J, Dietrich S, Meissner J et al (2010) Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy. Leuk Lymphoma 51:2012-2020
36. Greil R, Holzner B, Kemmler G et al (1999) Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994. Eur J Cancer 35:698-706
37. Heutte N, Flechtner HH, Mounier N et al (2009) Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 10:1160-1170
38. Miltenyi Z, Magyari F, Simon Z et al (2010) Quality of life and fatigue in Hodgkin's lymphoma patients. Tumori 96:594-600
39. Norum J, Wist EA (1996) Quality of life in survivors of Hodgkin's disease. Qual Life Res 5:367-374
40. Chalder T, Berelowitz G, Pawlikowska T et al (1993) Development of a fatigue scale. J Psychosom Res 37:147-153
41. Smets EM, Garssen B, Bonke B et al (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315-325
42. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483
43. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
44. Nyenhuis DL, Yamamoto C, Luchetta T et al (1999) Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55:79-86
45. Abernethy AP, Zafar SY, Uronis H et al (2010) Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage 40:545-558
46. Browne JP, O'Boyle CA, McGee HM et al (1997) Development of a direct weighting procedure for quality of life domains. Qual Life Res 6:301-309
47. Loge JH, Ekeberg O, Kaasa S (1998) Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 45:53-65